Zobrazeno 1 - 10
of 181
pro vyhledávání: '"Franco, Citterio"'
Autor:
Filippo Paoletti, Vittori Giorgio, Adel Jaser, Natalia Romina Zanoni, Walter Ricciardi, Franco Citterio, Antonio Giulio De Belvis
Publikováno v:
BMC Health Services Research, Vol 23, Iss 1, Pp 1-11 (2023)
Abstract Background Rising incidence and prevalence of end-stage renal disease is a worldwide concern for sustainability of healthcare systems and societies. Living donor renal transplant [LDRT] provides highest health achievements and cost containme
Externí odkaz:
https://doaj.org/article/d5bde49fdb2d4dc2b676608b892a4f55
Autor:
Marianna Morani, Fausto Baldanti, Fabio Ciceri, Franco Citterio, Mariano Ferraresso, Corrado Girmenia, Umberto Maggiore, Massimo Martino, Francesco Onida, Luciano Potena, Fabio Vistoli, Paolo Antonio Grossi
Publikováno v:
AboutOpen, Vol 10, Iss 1 (2023)
Background: Cytomegalovirus (CMV) infection usually occurs asymptomatically but can represent an important cause of morbidity and mortality in patients with compromised immune system such as transplant patients. Infection may not respond to standard
Externí odkaz:
https://doaj.org/article/4a3a2b26fda44dc2ad428b68501f6e73
Publikováno v:
Transplantation Reports, Vol 7, Iss 4, Pp 100112- (2022)
Summary: Kidney transplantation is the best treatment available for patients with end-stage renal disease. There are three categories of donors: living donors (LD), brain death (DBD) or cardiac death (DCD) kidney donors. In this review we analyze the
Externí odkaz:
https://doaj.org/article/a38114f3c74a43558377112df27da1ef
Autor:
Delia Mercedes Bianco, Flavio De Maio, Giulia Santarelli, Ivana Palucci, Alessandro Salustri, Giada Bianchetti, Giuseppe Maulucci, Franco Citterio, Maurizio Sanguinetti, Enrica Tamburrini, Michela Sali, Giovanni Delogu
Publikováno v:
Antibiotics, Vol 12, Iss 1, p 171 (2023)
Even though Everolimus has been investigated in a phase II randomized trial as a host-directed therapy (HDT) to treat tuberculosis (TB), an oncological patient treated with Everolimus for a neuroendocrine pancreatic neoplasia developed active TB twic
Externí odkaz:
https://doaj.org/article/468aae48e4394f7ea81d8e17376e81f6
Autor:
Alexandre Loupy, Olivier Aubert, Gillian Divard, Christophe Legendre, Julio Pascual, Claudia Sommerer, Federico Oppenheimer, Franco Citterio, Helio Tedesco, Steve Chadban, Mitchell Henry, Flavio Vincenti, Titte Srinivas, Yoshihiko Watarai, Peter Bernhardt
Publikováno v:
BMJ Open, Vol 11, Iss 10 (2021)
Objectives Development of pharmaceutical agents in transplantation is currently limited by long waits for hard endpoints. We applied a validated integrative risk-prognostication system integrative Box (iBox) as a surrogate endpoint to the TRANSFORM S
Externí odkaz:
https://doaj.org/article/a7070933a5104b9d94f837a1dc93cc94
Autor:
Giovanni Gambaro, Alessandro Naticchia, Pietro Manuel Ferraro, Gionata Spagnoletti, Jacopo Romagnoli, Maria Paola Salerno, Franco Citterio
Publikováno v:
Kidney & Blood Pressure Research, Vol 44, Iss 5, Pp 1306-1312 (2019)
Introduction: Dent’s disease is a rare X-linked recessive disorder that manifests in childhood or early adulthood and can lead to end-stage renal disease (ESRD). It occurs in males, who are hemizygous. In patients who develop ESRD, a deceased donor
Externí odkaz:
https://doaj.org/article/3e263ec0813040e4aee2b6c3868101b7
Autor:
Martina Taborelli, Federica Toffolutti, Stefania Del Zotto, Elena Clagnan, Lucrezia Furian, Pierluca Piselli, Franco Citterio, Loris Zanier, Giuliano Boscutti, Diego Serraino, for the Italian Transplant & Cancer Cohort Study
Publikováno v:
BMC Nephrology, Vol 20, Iss 1, Pp 1-8 (2019)
Abstract Background In southern Europe, the risk of cancer in patients with end-stage kidney disease receiving dialysis has not been well quantified. The aim of this study was to assess the overall pattern of risk for de novo malignancies (DNMs) amon
Externí odkaz:
https://doaj.org/article/45285e9bfe3e4130912801b08b8545f8
Autor:
Piero Ruggenenti, Paolo Cravedi, Eliana Gotti, Annarita Plati, Maddalena Marasà, Silvio Sandrini, Nicola Bossini, Franco Citterio, Enrico Minetti, Domenico Montanaro, Ettore Sabadini, Regina Tardanico, Davide Martinetti, Flavio Gaspari, Alessandro Villa, Annalisa Perna, Francesco Peraro, Giuseppe Remuzzi
Publikováno v:
PLoS Medicine, Vol 18, Iss 6, p e1003668 (2021)
BackgroundWe compared protection of mycophenolate mofetil (MMF) and azathioprine (AZA) against acute cellular rejection (ACR) and chronic allograft nephropathy (CAN) in kidney transplant recipients on steroid-free, low-dose cyclosporine (CsA) microem
Externí odkaz:
https://doaj.org/article/30a39c55f59b4510a7e3ebcf1fd81bf6
Autor:
Claudia Sommerer, Christophe Legendre, Franco Citterio, Yoshihiko Watarai, Rainer Oberbauer, Nikolina Basic-Jukic, Jackie Han, Apurva Gawai, Peter Bernhardt, Steve Chadban
Publikováno v:
Transplantation.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bd5c988565ca5f72797e4843898452bb
https://doi.org/10.1097/tp.0000000000004555
https://doi.org/10.1097/tp.0000000000004555
Autor:
Pierluca Piselli, Diego Serraino, Claudia Cimaglia, Lucrezia Furian, Luigi Biancone, Ghil Busnach, Nicola Bossini, Paola Todeschini, Maurizio Iaria, Franco Citterio, Mariarosaria Campise, Massimiliano Veroux, Giuseppe Tisone, Vincenzo Cantaluppi, Margherita Mangino, Simona Simone, Davide Argiolas, Andrea Ambrosini, Francesco Pisani, Flavia Caputo, Martina Taborelli
Publikováno v:
Cancers
Volume 15
Issue 4
Pages: 1347
Volume 15
Issue 4
Pages: 1347
This cohort study examined 25-year variations in cancer incidence among 11,418 Italian recipients of kidney transplantation (KT) from 17 Italian centers. Cancer incidence was examined over three periods (1997–2004; 2005–2012; and 2013–2021) by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::258ac33a08283a6a1d2c27abb66d4f20
https://hdl.handle.net/11577/3476257
https://hdl.handle.net/11577/3476257
